# Arcus Biosciences, Inc. (RCUS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Arcus Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RCUS/mda/fy2025/): filed 2026-02-25; accession 0001724521-26-000009 (https://www.sec.gov/Archives/edgar/data/1724521/000172452126000009/rcus-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RCUS/mda/fy2024/): filed 2025-02-25; accession 0001724521-25-000040 (https://www.sec.gov/Archives/edgar/data/1724521/000172452125000040/rcus-20241231.htm)
- [FY 2023 MD&A](/company/RCUS/mda/fy2023/): filed 2024-02-21; accession 0001724521-24-000052 (https://www.sec.gov/Archives/edgar/data/1724521/000172452124000052/rcus-20231231.htm)
- [FY 2022 MD&A](/company/RCUS/mda/fy2022/): filed 2023-02-28; accession 0000950170-23-005112 (https://www.sec.gov/Archives/edgar/data/1724521/000095017023005112/rcus-20221231.htm)
- [FY 2021 MD&A](/company/RCUS/mda/fy2021/): filed 2022-02-23; accession 0000950170-22-001788 (https://www.sec.gov/Archives/edgar/data/1724521/000095017022001788/rcus-20211231.htm)

Back to /company/RCUS/